All type of patients: 3 trials - MONALEESA-3 - MONALEESA-2 - MONALEESA-7
| ribociclib (LEE011) + letrozole vs letrozole alone | progression or death (progression free survival PFS) by 44% (fully demonstrated) | |
| ribociclib (LEE011) + nsAI/TAM gos vs nsAI/TAM + gos | No demonstrated result | |
| ribociclib (LEE011)+ fulvestrant vs fulvestrant alone | No demonstrated result |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
